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Abstract
Background: Mucosal atrophy as a potential cause of impaired colonic compliance has not yet been described as
a complication in Collagenous Colitis (CC).
Case presentation: We present a 51-year-old female patient with a 20-year history of diarrhea and diagnosed with
CC ten years prior to her presentation. We reviewed reports from three colonoscopies performed after the
diagnosis. Overall 12 biopsies obtained in the last two colonoscopies were re-analyzed by two pathologists blinded
to the aim of the study. Besides the typical histological findings of CC, the endoscopic appearance was normal,
and no histological signs of atrophy were found during the first colonoscopy. Surprisingly, the second and third
colonoscopy revealed a region of advanced segmental mucosal atrophy in the cecum with the mucosal height
normalizing toward the transverse colon. This pattern of atrophy was inversely related to the pattern of sub-
epithelial collagen deposition, which increased toward the rectum.
Conclusion: If no chance occurrence, our observation supports the idea that additional factors, probably luminal in
nature, may be co-responsible for the mucosal atrophy in this case. Thus, mucosal atrophy in the proximal colon
appears to be a new candidate among the growing list of rare complications associated with long standing CC.
Background
Collagenous colitis (CC) is a chronic inflammatory
bowel disease characterized by chronic watery, non-
bloody diarrhea in the context of macroscopically nor-
mal appearing colonic mucosa on endoscopic examina-
tion. CC was first described in 1976 [1]. Although it was
initially underestimated, it became apparent that CC
may be responsible for up to 5% of the cases investi-
gated for chronic, watery diarrhea [2]. The disease
affects middle-aged and elderly women with a peak inci-
dence around 65 years and a female:male ratio of
approximately 7:1 [3]. Over the last few years, several
complications of CC have been reported [4], and some
of these have been related to the impaired integrity of
the colonic wall. Lesions have been described ranging
from surface epithelial cell sloughing [5] to sub-mucosal
“dissections” [6] and colonic wall tears after endoscopic
instrumentation [7]. In a systematic review, Wickbom
and co-workers postulated that the impaired compliance
of the collagen-containing mucosa was responsible for
the tearing of the mucosa by air distension during colo-
noscopy [8]. Mucosal atrophy, another potential cause
of impaired colonic compliance, was neither reported in
these cases nor described as a complication of CC [3,5].
Herein we report for the first time the development of
an almost fully established mucosal atrophic lesion in
the proximal colon of a patient with long standing CC.
Case presentation
A 51-year-old female with a 20-year history of chronic
diarrhea was admitted to our gastroenterological rehabi-
litation center in 2008. Her stool consistency was
described as pulpy, and neither blood nor mucus was
reported. Her weight (body mass index (BMI): 19 kg/
m
2) had remained constant during the prior months.
The physical examination revealed no further specific
findings. Routine laboratory tests were within normal
values with the exception of decreased serum ferritin
levels measured at 9.1 ng/ml (normal: 25 to 120 ng/ml).
The diagnosis of CC had been established 10 years prior
in 1998 at our center. At the time of diagnosis, the
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2). She had a
history of radioiodine therapy for hyperthyroidism.
Three years prior, invasive tubulo-ductal breast cancer
(pT1c, grade I-II) was diagnosed in her left breast, and a
breast saving R0 resection was performed. Postoperative
radiotherapy followed by anti-estrogen therapy with leu-
porelin and tamoxifen was delivered. Family history was
notable for one of her three sisters who had developed
Crohn’s disease. After the diagnosis of CC was made,
she was initially treated with Plantago ovata. In 2002,
the patient’s weight decreased again by 4 kg to 44 kg
(BMI: 16.6 kg/m
2). One year later, in 2003, a diagnosis
CC was corroborated by endoscopic findings at another
center and treated with budesonide for two years, result-
ing in a weight gain of approximately 4 kg. Budesonide
was then gradually switched to mesalamine due to the
development of osteoporosis. The presence of celiac dis-
ease was excluded with normal duodenal biopsies and
negative serologic testing. During her inpatient rehabili-
tation, the third colonoscopy was performed. Parts of
the endoscopic and histologic results are shown in Fig-
ures 1 and 2. In summary, an advanced mucosal
atrophic lesion was diagnosed in the proximal colon,
and typical signs of CC were still present. In addition,
we examined the reports and endoscopic images
obtained from the colonoscopies in 1998, 2003 and
2008. Two pathologists re-analyzed all available biopsies
independently and blinded to the aims of the study. The
2003 specimens revealed a medium height of 188 μmo f
the cecal and a 260 μm height of the rectal mucosa,
while 172 μm and 262 μm were measured in the corre-
sponding 2008 specimens (Figure 3). Signs of mucosal
atrophy were not present on the histological-reports or
protocols from the 1998 colonoscopy nor were they
apparent in the available photographic documentation
of the 1998 procedure (Figure 1). Budesonide, calcium
and vitamin D were prescribed, and the patient was
released in a subjectively improved clinical condition
with a goal to taper budesonide as fast as possible due
to her developing osteoporosis.
Discussion
We have described a patient with greater than a 10-year
history of CC who developed segmental mucosal atro-
phy involving the ascending colon while sparing the
terminal ileum and the remaining segments of the
colon. Although, we were not able to obtain a clear-cut
and internationally accepted definition of mucosal atro-
phy, the presence of advanced atrophy in the cecal
region of our patient is beyond any reasonable doubt
( F i g u r e1 ,2 0 0 8e n d o s c o p i ci m a g ea n dc o r r e s p o n d i n g
histology on the bottom). According to established his-
tological textbooks and also according to our own long-
time experience, the normal mucosal thickness is
between 400-500 μm [9]. In our opinion, these data cor-
respond well to our morphometric finding with a med-
ian 188 μm mucosal height in the overtly “atrophic”
cecum (Figure 3). However, from Figure 3 it also
appears that the apparent mucosal height in the non-
atrophic rectum as shown in Figure 2 was rather low
with a median height of 262 μm in 2008. This may be
Figure 1 The 2008 endoscopic image displays a pale,
translucent mucosal region from the cecum with prominent a
submucosal vascular pattern indicating advanced atrophy. For
comparison the endoscopic image form 1998 displays a normal
aspect of cecal mucosa. Please note, the digitally reproduced instant
camera image from 1998 displays a somewhat lower resolution. The
corresponding histology (hematoxilin and eosin staining)
corroborates the endoscopic impression. The height of the cecal
mucosa (138 μm [range: 128 - 146 μm]) was dramatically reduced in
2008. Almost no significant sub-epithelial collagen band thickening
could be demonstrated in the atrophic cecal mucosa.
Figure 2 The normal-appearing rectal mucosa from 2008 is
shown. A small part of the muscular mucosal layer is indicated by
the arrowhead at the right side of the low-magnified image. In
contrast, extensive collagen band thickening could be seen in the
rectal biopsies (arrowhead in the high-magnified image of the sub-
epithelium beneath a vertically-cut crypt). Of note, amyloidosis was
excluded with special staining (results not shown).
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standard biopsies with limited penetration may not
allow for a reliable assessment of mucosal heights
beyond a certain threshold.
To our knowledge, such a development of advanced
colonic mucosal atrophy has not been documented in
the CC literature thus far [3]. Prior to this report,
microscopic signs of atrophy in the mucosal lining of
the colon were described in only one CC patient by
Otegbayo and co-workers [10]. With respect to the time
course of the development of mucosal atrophy we
observed almost stable mucosal heights comparing cecal
and rectal biopsies from 2003 and 2008 (Figure 3). This
suggests that cecal atrophy may have evolved before
2003. On the other hand, the 1998 photo documenta-
tion (Figure 1) and the endoscopical and histological
reports do not support presence of clinically apparent
cecal atrophy in 1998. Please note, that comparing the
1998 and 2008 endoscopical images in Figure 1 is some-
what compromised by different resolutions owned to
digital reproducing the 1998 original instant camera
image. So one may be tempted to pin the start of atro-
phy to sometime between 1998 and 2003. As the biop-
sies from 1998 were not available for re-analysis, we
cannot rule out that incipient histological signs of cecal
atrophy may have been present already at that time.
H o w e v e r ,i ts e e m st ob em o r el i k e l yt h a te v o l v e m e n to f
clinical relevant mucosal atrophy may be better
described as late-term sequela of CC.
As expected the number of intraepithelial lymphocytes
(IELs) was increased in all parts of the colon (Figure 3).
Notably, in ulcerative colitis, Crohn’s colitis and infec-
tious colitis IELs are usually not increased. However, a
lymphocytic colitis-like pattern in Crohn’s disease has
been described and may precede the eventual diagnosis
of Crohn’s disease [11]. In our case the initial symptoms
go back into the year 1998, i.e. a 12-year-follow-up. In
three endoscopic and histological examinations, the clin-
ico-pathological features of Crohn’s disease were not ful-
filled, by this rendering the diagnosis of Crohn’sd i s e a s e
highly unlikely. In addition, we excluded other concur-
rent diseases associated with segmental mucosal atro-
phy, such as ischemic colitis. Although not in the colon,
advanced mucosal atrophy has been observed in the
duodenum and ileum of patients with CC and celiac dis-
ease [12]. However, our patient’s duodenal and ileal
biopsies did not display any signs of mucosal atrophy. In
addition, her serologic tests for celiac disease were
negative.
A chance occurrence would be another explanation
for the presence of mucosal atrophy with CC in our
patient. This type of bias is always relevant for case
reports, especially if findings that display a high preva-
lence are reported in patients with rare diseases. How-
ever, after excluding patients with inflammatory bowel
disease, the population based prevalences of CC and
advanced mucosal atrophy of the proximal colon are
comparatively low [3]. Thus, the probability of a random
coincidence of these entities seems to be small, although
not nil. Regarding the rather profound mucosal atrophy
observed in our patient (Figure 1, 2008 endoscopical
image and histology), it is noteworthy to mention that
additional more extensive damage of the colonic
mucosa, such as ulcerations, have also been described in
CC patients. Some observations indicate a possible
Figure 3 The mucosal height and the thickness of the sub-
epithelial collagen band are shown as assessed by two
observers who were blinded to the aim of the study (observer
ratings indicated as black squares and dots). The results
obtained in specimens from the 2003 colonoscopy are connected
with dotted lines and those from the 2008 procedure with
continuous lines. The semi-quantitative assessment of the
lymphocytic infiltrate is shown as table at the bottom of the figure.
The results on the semi-quantitative analysis of intraepithelial
plasma cells, eosinophils and neutrophils are not shown as they
parallel the results for the lymphocytic infiltrate.
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such as non-steroidal anti-inflammatory drugs [13].
However, our patient took neither nonsteroidal anti-
inflammatory drugs nor did she receive chemotherapy
or drugs postulated to be associated with CC or mucosal
atrophy [14,15]. Beside drug-induced aggravation of
mucosal damage, several other observations indicate a
more profound impairment of the colonic wall integrity
in some patients with CC. Rarely, sub-mucosal dissec-
tions have been described probably alongside the col-
lagen band, [6] and Wickbom and colleagues reviewed a
total of 12 patients with mucosal tears and CC [8].
Interestingly, in 10 patients, the mucosal lacerations
involved the ascending or the transverse colon, the same
exact segments that we observed in the advanced muco-
sal atrophy in our patient.
Considering that the histopathological abnormalities
in CC are believed to be most prevalent in the proxi-
m a lc o l o na n dt h a tt h es i g m o i dc o l o na n dr e c t u mm a y
be spared in up to 73% of cases, [16] it has been
speculated, that the integrity of the proximal colonic
wall may be predominantly compromised owing to the
extent of sub-mucosal collagen deposition [5,8].
Although, we were not able to identify any relation
between the inflammatory cellular infiltrates and
mucosal atrophy in the 2003 and 2008 specimens, we
have clearly demonstrated that the sub-epithelial col-
lagen band thickening was consistently described to be
maximal in rectal biopsies from all three colonoscopies
in our patient (Figure 2). This was corroborated by the
morphometric re-analysis of the biopsies from 2003
and 2008 (Figure 3). Additionally, despite there being
areas of less collagen band thickening for many years,
the cecum and ascending colon were the segments
where we observed the maximum atrophy of the colo-
nic mucosa (Figure 1 and 3). This mismatch does not
support a direct relationship between the extent of col-
lagen deposition and the development of atrophy in
o u rp a t i e n t .R a t h e r ,o u rf i n d i n g sf o s t e rt h ea s s u m p t i o n ,
also shared by others [17], that at least sometimes
additional luminal factors in combination with the col-
lagen deposits probably influence the activity of CC
and thereby propagate mucosal atrophy and colonic
wall friability in susceptible patients.
Conclusion
Our observation introduces the mucosal atrophy of the
proximal colon as a novel candidate complication that
may be associated with long-standing CC.
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